Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top

Invitation Letter | Morimatsu invites you to participate in the 9th E-commerce Biotech Industry Conference and Exhibition

BIOCHINA 2024(EBC)
The 9th E-commerce Biotech Industry
Conference and Exhibition
"Cooperation Accelerates Innovation”

Exhibition information
Three Systems of "Exhibition - Conference - Activity”
50,000㎡ exhibition area
30,000+ audience
500+ exhibitors
800+ speakers
Innovation has become a timeless direction encouraged by policies. Cooperation has become the best choice for market-driven development. Under the joint planning and promotion of multi-partner institutions and content partners, this exhibition will focus on innovative technology and product development; besides, look at project cooperation and business expansion at home and abroad, aiming to promote cooperation and exchanges between China biomedical enterprises and global partners.
Exhibition Time
14 -16 March
Exhibition Venue
Suzhou International Expo Center
Morimatsu Booth
D3 Excellent Brand Hall D023
Booth renderings
Booth renderings
Booth renderings
Booth renderings
Booth renderings
Booth renderings
Invitation Letter | Morimatsu invites you to participate in the 9th E-commerce Biotech Industry Conference and Exhibition
Morimatsu Booth
Morimatsu will once again demonstrate its outstanding strength at this grand event, bringing a one-stop overall laboratory solution and a VR simulation training system. Through sharing technical experience with the elites in the industry, we will discuss future development trends and industry focus.
One-stop overall laboratory solution
This solution includes upstream culture solutions, downstream separation and purification solutions and disposable system solutions, aiming to help users accelerate the research and development process and meet the challenges at different stages.
Upstream Culture Solution
MOCELLULA™ WAV-2D Single-Use Bioreactor
MOCELLULA™ GBR/GFE Glass Bioreactor
MOCHROMA™ QBE Desktop Chromatography System
Downstream Separation and Purification Solution
MOPROCESS™ SUI Single-Use Online Liquid Preparation/Cracking System
MOPURITY™ SUF Single-Use Tangential Flow Filtration System
MOCELLULA™ WAV Wave Bioreactor
Intelligent microfluidic synthesizer IMD-L
Single-Use Solution
MOTRANSIT™MIX/STOSingle-Use Liquid Distribution and Storage System
MOCELLULA™ SUBSingle-Use Bioreactor
Single Use SystemSingle-Use Consumables Use System
VR Simulation Training System
Experience Morimatsu's digital wisdom on site in an immersive interactive environment. Effectively reduce security risks, and complete training with high quality.

In early spring, let us met in Suzhou.
We sincerely look forward to your visit to the
booth and experience more exciting activities.
END

About Morimatsu LifeSciences
Morimatsu LifeSciences, one of the key business segments of Morimatsu International Holding Co., Ltd. (Morimatsu International, stock code: 2155.HK), mainly consists of Shanghai Morimatsu Pharmaceutical Equipment Engineering Co., Ltd., Morimatsu (Suzhou) Life Technology Co., Ltd., Shanghai Morimatsu Biotechnology Co., Ltd., Pharmadule Morimatsu AB (Sweden) and its subsidiaries, which serves the pharmaceuticals, bio-pharmaceutical, cosmetic medicine, FMCG (cosmetics, baby, women & home Care, health care, fabric & home care, food, beverage, nutraceuticals) and other industries, providing customers with "core equipment+value-added services+digital intelligent overall factory solutions and services" ("MVP Solutions&Services"), focusing on core equipment, stainless steel process systems, disposable process systems, consumables, laboratory solutions, digital and modular factory solutions and services.
As a diversified multinational company, Morimatsu has opened subsidiaries or advanced manufacture plants in China, Japan, Sweden, United States, India, Italy, Singapore, and has delivered different forms of products and services to more than 40 countries and regions so far, by its global footprint of an efficient and professional team.

Forward-Looking Statements
The information in this press release may include some forward-looking statements. Such statements are essentially susceptible to considerable risks and uncertainties. The use of "predicted", "believed", "forecast", "planned" and/or other similar words/phrases in all statements related to our company is to indicate that the statements are forward-looking ones. Our Company undertakes no obligation to constantly revise such predicted statements.
Forward-looking statements are based on our Company management's current perspectives, assumptions, expectations, estimations, predictions and understanding of future affairs at the time of the making of such statements. Such statements are not guarantees of future development and are susceptible to the impact of risks, uncertainties and other factors; some are beyond the control of our Company and unpredictable. Subject to the influence of future changes and development in our business, competition environment, political, economic, legal and social conditions, the actual outcomes may differ significantly from the information contained in the forward-looking statements.
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only. Read more
1
+0
Translate
Report
3033 Views
Comment
Sign in to post a comment